AAP Releases

Cision

Page 33 of 2665

March 26, 2026

Keypoint Intelligence's Deborah Hawkins Named Judge for 2026 Technology Reseller Awards

PRNewswire

March 26, 2026

Axi Launches "The Strategy Room" Podcast Hosted by Kathy Lien

PRNewswire

March 26, 2026

Heidi Receives Frost & Sullivan's 2026 North American Technology Innovation Leadership Recognition for Excellence in Artificial Intelligence Medical Scribe Innovation

PRNewswire

March 26, 2026

Frost & Sullivan: Locus FS Receives the 2026 North American Precision Fermentation Technology Innovation Leadership Recognition for Excellence in Platform-Driven Biological Innovation

PRNewswire

March 25, 2026

Axtria Recognized as Frost & Sullivan's 2025 Global Company of the Year in Pharma Commercial Solutions

PRNewswire

March 25, 2026

Saramonic Launches Ultra-Compact Dual-Form Saramonic Air SE to Define Portable Audio for Mobile Creators

PRNewswire

March 25, 2026

Enterprise AI Finds its Voice: ElevenLabs and IBM Bring Premium Voice Capabilities to Agentic AI

PRNewswire

March 25, 2026

Bitmine Immersion Technologies (BMNR) Announces Launch of MAVAN (Made In America VAlidator Network), the Company's Proprietary Staking Solution

PRNewswire

March 25, 2026

Manchester United and Moroccan International Noussair Mazraoui becomes strategic partner with the world's leading Islamic Fintech, Wahed

PRNewswire

March 25, 2026

SF Holding Upgraded to "AA" in MSCI ESG Ratings, Reinforcing Its Global Leadership in Sustainable Logistics

PRNewswire

March 25, 2026

Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs

PRNewswire

March 25, 2026

ENNOVI Secures German Patent Approval for Adhesive-Free Lamination in Battery Cell Contacting Systems

PRNewswire

March 25, 2026

GAC's First Overseas Service Brand Launches at Bangkok Motor Show, Thailand Action 2.0 Commences

PRNewswire

March 25, 2026

VERIGRAFT Advances First Potential Curative Treatment for CVI into Pivotal Phase II/III Trial

PRNewswire